FDA approves first at-home cervical cancer test

The latest stories trending on MedCity News.

Editor's Pick

Top Story FDA Approves First At-Home Cervical Cancer Test Teal Health received FDA approval for the first-ever at-home cervical cancer test, which seeks to give patients an alternative to the in-office pap smear. The test is already covered by four major payers in California. Sponsored Get a Snapshot of the Early Stage Life Science Startup Landscape Presented by Mercury In this webinar, the panel will explore how early-stage medtech and biopharma investors are looking at the market and how they're advising startups in the wake of cuts to NIH and SBIR grants. Sign up to watch now! Only 2 Weeks Away! With just two weeks left until INVEST 2025 Chicago, now is the time to join healthcare's brightest minds for two days of insight, innovation, and opportunity. INVEST 2025, "Where Capital Meets Innovation," takes place May 20-21 at Willis Tower and brings together investors, startups, and industry leaders to tackle healthcare's biggest challenges. Register Now

Featured News

Priority Health Taps Ayble Health to Address GI Disorders Through a new partnership, Priority Health members will be able to receive virtual gastrointestinal care from Ayble Health. AI's Next Act: New Medicines We may be on the eve of the next breakthrough: a new combination of "old" algorithms that promises to radically accelerate the discovery and development of new medicines. Patient-Centricity is Reliant on Representative Clinical Studies Recent FDA guidance aims to improve research inclusivity and the generalizability of clinical findings by ensuring diverse participant representation — it's about better science, improved patient outcomes, and equitable healthcare access.

Video   Adding Up the Costs of Medicare Advantage Proponents of Medicare Advantage say that these plans are cost effective and help seniors pay less. However, the Medicare Payment Advisory Commission (MedPAC) — which advises Congress on Medicare policies — recently released a report showing that in 2025, CMS will have spent $84 million more on Medicare Advantage enrollees than if those same individuals were enrolled in traditional Medicare. Still, many seniors say that Medicare Advantage plans suit them better because of low premiums and out-of-pocket costs. So how does this all add up? The government is paying more for Medicare Advantage enrollees, yet these same enrollees are paying less — who makes up the difference?

Sponsored The 4 Best Places to Buy Affordable Spectrometers for Lab Use Presented by OceanOptics Equip your laboratory with cost-effective instruments. Explore the top four companies for affordable spectrometers. Learn More

Resources

MedCity FemFwd: Improving the Collection of Maternal Health Data In this episode, we're joined by Maggie McCullough, CEO of PolicyMap. She discusses what's wrong with the way maternal health data is collected at the federal level and ways it can be improved. Listen now

MedCity News • PO Box 901 • New York, NY unsubscribe